The End of Standard Berberine Absorption Failures
DiBerberine 300x is an advanced, uniquely engineered dietary supplement designed to solve the critical absorption failures of standard berberine. Featuring an acid-resistant vegetable capsule, 500 mg of dihydroberberine, and our patent-pending RGBooster1™ complex, it is built to deliver unprecedented bioavailability.
The Engineering Behind the Formula
Manufactured by RevGenetics in Miami, FL, DiBerberine 300x represents a paradigm shift in supplementation. It explicitly targets and neutralizes the three primary biological barriers that prevent standard berberine from reaching your target cells.
- Barrier 1: Stomach Acid Degradation. Standard capsules dissolve in the stomach, destroying delicate active compounds. We use an acid-resistant capsule that only releases in the higher pH of the small intestine.
- Barrier 2: Poor Intestinal Permeability. We use Dihydroberberine (DHB), the reduced, hydrogen-enriched form of berberine, which crosses intestinal membranes significantly better than standard berberine HCl.
- Barrier 3: Cellular Ejection. Intestinal cells use P-glycoprotein (P-gp) efflux pumps to actively eject berberine back into the gut. Our patent-pending RGBooster1™ complex modulates these pumps to maximize systemic absorption.
Inside the 500mg Master Formula
Each bottle provides 30 acid-resistant vegetable capsules packed with a balanced matrix of three core components:
- Dihydroberberine (DHB): A pharmacokinetic study found 100 mg DHB produced approximately 6.7× greater plasma berberine exposure than 500 mg berberine HCl, from one-fifth the dose.1
- RGBooster1™: RevGenetics formulated this patent-pending flavonoid complex to achieve 300× greater P-gp modulation than piperine at this specific mechanism.
- L-Leucine: A branched-chain amino acid included to support mTOR pathway signaling alongside AMPK activation.
| Feature | Standard Berberine Supplements | DiBerberine 300x |
|---|---|---|
| Active Compound | Berberine HCl | Dihydroberberine (DHB) |
| Capsule Delivery | Standard Gelatin or Veggie (Dissolves in stomach) | Acid-Resistant Enteric (Bypasses stomach acid) |
| P-gp Efflux Modulator | None | Patent-Pending RGBooster1™ |
| mTOR Pathway Support | None | L-Leucine |
Why DiBerberine 300x Exists: A Note from the Founder
"I started RevGenetics in Miami because I was looking for a berberine product that actually solved the absorption problem, not just described the problem on the label and sold you a standard capsule anyway. After researching the pharmacokinetics, I understood why most berberine products underperform: the capsule dissolves in stomach acid before the compound reaches the small intestine, and P-glycoprotein efflux pumps eject what little survives. I couldn't find a product that addressed both barriers. So I built one. DiBerberine 300x is that product, engineered from Miami, manufactured in the USA, built for the buyer who actually reads the science."
- Anthony Loera, Founder, RevGenetics
Manufacturing & Efficacy Timeline
DiBerberine 300x is manufactured in FDA-registered, cGMP-certified facilities right here in the USA and undergoes strict independent third-party testing for purity and potency. When taken as directed, users can expect to see effects on energy metabolism and AMPK activation beginning to appear around 6-8 weeks of consistent, daily use, with peak observations in the 6-12 week window.
Experience Unprecedented Bioavailability - Order DiBerberine 300x Today
Frequently Asked Questions
Who makes DiBerberine 300x?
DiBerberine 300x is manufactured by RevGenetics, founded by Anthony Loera and based in Miami, FL. It is produced in a USA-based cGMP-certified facility and independently third-party tested for purity and potency. The RGBooster1™ formulation is covered by a patent application filed with the USPTO.
Why does L-Leucine matter in DiBerberine 300x?
AMPK activation transiently affects mTOR, the cellular pathway involved in signaling. L-Leucine is a branched-chain amino acid involved in mTOR pathway signaling. DiBerberine 300x includes L-Leucine alongside DHB and RGBooster1™. No other DHB supplement on the market includes this combination in one capsule.
What is the difference between dihydroberberine and berberine?
Dihydroberberine (DHB) is the reduced form of berberine with substantially higher oral bioavailability. A 2022 pharmacokinetic study found that 100 mg DHB produced approximately 6.7× greater plasma berberine exposure than 500 mg berberine HCl, from one-fifth the dose. Once inside cells, DHB converts to berberine and activates AMPK.
How long does DiBerberine 300x take to work?
DHB/berberine activates AMPK through enzymatic pathways, not stimulant mechanisms. Users in berberine clinical literature consistently report effects on energy metabolism and AMPK activation beginning to appear at the 6-8 weeks mark with consistent daily use. The most significant observations typically occur in the 6-12 week window. Consistency matters, daily use is required for cumulative AMPK activation benefits.
What makes enteric-coated DHB different from standard DHB supplements?
Enteric-coated DHB uses an acid-resistant capsule that bypasses the stomach entirely, dissolving only in the small intestine where absorption occurs. Standard DHB capsules dissolve in stomach acid, converting DHB back to regular berberine before absorption. DiBerberine 300x adds RGBooster1™, a patent-pending P-glycoprotein efflux modulator, to address the secondary intestinal barrier.
Scientific References
1. Pharmacokinetic Study (PMC8746601): Evaluation of Dihydroberberine bioavailability compared to Berberine HCl.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
